SHIFT Trial for Improving Stroke Recovery
SDOH-Homecare Intervention Focus Team (SHIFT) Trial to Improve Stroke Outcomes
Recruiting
N/A
Interventional Study
Stroke
Social Determinants of Health
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 275 (estimated)
- Sponsor
- Columbia University · Other
Who this trial is looking for
This trial is looking for stroke patients aged 18-75 who have at least three social and health-related challenges. Participants will receive homecare support to help improve their recovery over 6 months to a year.
Are You a Good Fit for This Trial?
You may be able to join if
- I have had an ischemic stroke or primary intracerebral hemorrhage.
- I am African American/Black or Hispanic.
- I am between 18 and 75 years old.
- I have at least 3 social or health-related challenges.
- I will go home after leaving the hospital or go to rehab before going home.
- My pre-stroke disability score was 3 or less.
- I live in New York City.
- I can speak English or Spanish.
You may not be able to join if
- I will be discharged to a long-term care facility.
- I have been diagnosed with dementia or a serious cognitive issue.
- I have active major depression.
- I have severe difficulty speaking that prevents my assessment.
- I have impaired consciousness when assessed.
- I have had a subarachnoid hemorrhage.
- I have been diagnosed with probable cerebral amyloid angiopathy.
- I have a life expectancy of less than 1 year.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Primary Goal:
To test the hypothesis that among stroke patients 18-75 years with ≥3 SDOH risk factors, SHIFT will improve: (1) functional outcomes as measured by the SIS (Primary Outcome), (2) physiological outcomes as measured by changes in blood pressure and cognition, (secondary outcomes) and (3) epigenetic allostatic load biomarkers (exploratory outcome) such as DNA methylation (DNAm) and tel…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Ischemic stroke (arterial subtypes) or primary intracerebral hemorrhage (excluding diagnosis of probable cerebral amyloid angiopathy by Boston Criteria)
* African American/Black or Hispanic race-ethnicity
* Age 18-75 years old
* Have at least 3 SDOH barriers from within the 5 …
Contacts